AU524000B2 - 4-(benzothiazole or benzoxadiazole)-1,4-dihydro-pyridine derivatives - Google Patents

4-(benzothiazole or benzoxadiazole)-1,4-dihydro-pyridine derivatives

Info

Publication number
AU524000B2
AU524000B2 AU37252/78A AU3725278A AU524000B2 AU 524000 B2 AU524000 B2 AU 524000B2 AU 37252/78 A AU37252/78 A AU 37252/78A AU 3725278 A AU3725278 A AU 3725278A AU 524000 B2 AU524000 B2 AU 524000B2
Authority
AU
Australia
Prior art keywords
compound
carbon atoms
alkyl
hydrogen
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU37252/78A
Other languages
English (en)
Other versions
AU3725278A (en
Inventor
Neumann Peter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU3725278A publication Critical patent/AU3725278A/en
Application granted granted Critical
Publication of AU524000B2 publication Critical patent/AU524000B2/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU37252/78A 1977-06-20 1978-06-19 4-(benzothiazole or benzoxadiazole)-1,4-dihydro-pyridine derivatives Expired AU524000B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CHCH777520 1977-06-20
CH752077 1977-06-20
CHCH782865 1978-03-16
CH286578 1978-03-16

Publications (2)

Publication Number Publication Date
AU3725278A AU3725278A (en) 1980-01-03
AU524000B2 true AU524000B2 (en) 1982-08-26

Family

ID=25691589

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37252/78A Expired AU524000B2 (en) 1977-06-20 1978-06-19 4-(benzothiazole or benzoxadiazole)-1,4-dihydro-pyridine derivatives

Country Status (20)

Country Link
EP (1) EP0000150B1 (enExample)
JP (1) JPS54103876A (enExample)
AT (1) AT376220B (enExample)
AU (1) AU524000B2 (enExample)
CA (1) CA1105463A (enExample)
CY (1) CY1239A (enExample)
DE (1) DE2860708D1 (enExample)
DK (1) DK149855C (enExample)
ES (1) ES470917A1 (enExample)
FI (1) FI64938C (enExample)
HK (1) HK65184A (enExample)
IE (1) IE47212B1 (enExample)
IL (1) IL54948A (enExample)
IT (1) IT1105364B (enExample)
LU (1) LU88342I2 (enExample)
MY (1) MY8500041A (enExample)
NL (1) NL930126I2 (enExample)
NZ (1) NZ187617A (enExample)
PT (1) PT68191A (enExample)
SG (1) SG20584G (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH639659A5 (de) * 1978-12-18 1983-11-30 Sandoz Ag Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.
DK525179A (da) * 1978-12-18 1980-06-19 Sandoz Ag Fremgangsmaade til fremstilling af benzoxadiazoler og benzothiazoler
BE886259A (fr) * 1979-11-23 1981-05-20 Sandoz Sa Nouveaux medicament a base de derives de la 1,4-dihydropyridine, pour le traitement de l'insuffisance cerebrovasculaire ou a action spamolytique
CH655658B (enExample) * 1980-09-18 1986-05-15
FI813460A7 (fi) * 1980-11-10 1982-05-11 Sandoz Ag Uusia 4-(2,1,3-bentsoksadiatsol-4-yyli)- 1,4-dihydro- pyridiinijohdannaisia, niiden valmistusmenetelmä ja niitäsisältävät farmaseuttiset yhdistelmät.
EP0080220B1 (en) * 1981-11-17 1986-02-19 FISONS plc Dihydropyridines, methods for their production and their formulation and use as pharmaceuticals
DE3207982A1 (de) * 1982-03-05 1983-09-08 Bayer Ag, 5090 Leverkusen Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln
DE3208628A1 (de) * 1982-03-10 1983-09-22 Bayer Ag, 5090 Leverkusen Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
ZA83959B (en) * 1982-03-10 1984-09-26 Sandoz Ltd 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
FR2528431B1 (fr) * 1982-06-15 1986-01-10 Sandoz Sa Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation comme medicaments
FR2554109A1 (fr) * 1983-11-01 1985-05-03 Sandoz Sa Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation en therapeutique comme medicaments
IE57810B1 (en) * 1984-03-27 1993-04-21 Delagrange Lab 1,4-dihydropyridine derivatives,their preparation and their use
NL194389C (nl) * 1984-06-14 2002-03-04 Novartis Ag Werkwijze voor het bereiden van een vaste dispersie van een farmaceutisch actief middel dat een lage oplosbaarheid in water heeft, in een vaste matrix van een in water oplosbaar polyalkyleenglycol als drager.
GB8428552D0 (en) * 1984-11-12 1984-12-19 Sandoz Ltd Organic compounds
US5260321A (en) * 1984-11-12 1993-11-09 Sandoz Ltd. Use of 1,4-dihydropyridine derivatives and combinations thereof with calcitonins
GB8616047D0 (en) * 1986-07-01 1986-08-06 Sandoz Ltd A 1 4-dihydropyridine derivatives
EP2316468A1 (en) 2002-02-22 2011-05-04 Shire LLC Delivery system and methods for protecting and administering dextroamphetamine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552911A (en) * 1975-07-02 1979-09-19 Fujisawa Pharmaceutical Co 1,4 dihydropyridine derivatives and the preparation thereof

Also Published As

Publication number Publication date
IE781231L (en) 1978-12-20
MY8500041A (en) 1985-12-31
FI64938C (fi) 1984-02-10
IL54948A0 (en) 1978-08-31
PT68191A (fr) 1978-07-01
HK65184A (en) 1984-08-31
SG20584G (en) 1985-03-08
JPS54103876A (en) 1979-08-15
EP0000150B1 (en) 1981-05-20
DE2860708D1 (en) 1981-08-27
IL54948A (en) 1982-01-31
NL930126I1 (nl) 1993-11-01
AU3725278A (en) 1980-01-03
NZ187617A (en) 1980-12-19
FI64938B (fi) 1983-10-31
DK149855C (da) 1987-04-21
CA1105463A (en) 1981-07-21
IT1105364B (it) 1985-10-28
ATA443178A (de) 1984-03-15
ES470917A1 (es) 1979-10-01
AT376220B (de) 1984-10-25
CY1239A (en) 1984-06-29
JPS6360755B2 (enExample) 1988-11-25
DK149855B (da) 1986-10-13
LU88342I2 (fr) 1994-05-04
DK262578A (da) 1978-12-21
IE47212B1 (en) 1984-01-25
IT7849939A0 (it) 1978-06-19
EP0000150A1 (en) 1979-01-10
NL930126I2 (nl) 1995-02-16
FI781867A7 (fi) 1978-12-21

Similar Documents

Publication Publication Date Title
AU517474B2 (en) Piperidine or morpholine derivatives
AU510138B2 (en) Carbostyril derivatives
AU5848480A (en) 2-(pyrimidinyl-amino)-1,3-diaza-2-cycloalkene derivatives
AU3725278A (en) 4-(benzothiazole or benzoxadiazole)-1,4-dihydro-pyridine derivatives
AU1554776A (en) 1, 4-dihydro-pyridine derivatives
AU517661B2 (en) 5-[4-(diarylmethyl)-1-piperazinyl-alkyl]benzinidazole derivatives
AU514452B2 (en) 3, 3, 3-triarylalkyl-4-phenylalkl-4-hydroxy piperidine derivatives
AU6720087A (en) 4-(2-thiazolyl- and 4-(2-thiazolylamino-phenyl)-1,4- dihydropyridine derivatives
NL7803378A (nl) 5-(2-pyrroyl)-1.2-dihydro-3h-pyrrolo1.2-apyrrool-1- carbonzuurderivaten en werkwijzen ter bereiding ervan.
AU3431478A (en) Imadazo(5, 1-1)-1, 2, 4-triazines
AU3067377A (en) Piperidine derivatives
GB2041918B (en) 4-(naphthylmethyl) piperidine derivatives
AU506052B2 (en) Preparation of 2-(2, 2-dicyclohexylethyl) piperidine
AU522242B2 (en) 3-(TETRAZOL-5-yl)-1 AZAXANTHONES
PH13356A (en) 4-(3-alkylaminopropoxy)-indolse derivatives
AU534398B2 (en) 4-(naphthalenyloxy) piperidine derivatives
AU517110B2 (en) Raise drill
PH14805A (en) 4-(9,10-dihydro-4h-benzo(4,5)cyclohepta-(1,2-b)thiophen-4-ylidene)-piperidine derivatives
CU34933A (en) Tetrahydro-1,3,5 thiadiasine-4-ona derivatives
AU519175B2 (en) Raise drill
AU510611B2 (en) 4-(o-halophenyl)-1,2,4-triazole-3-thiols
AU516608B2 (en) Phenyl-2,3,4,5-tetrahydro-1h-3-benzazepine-7-8-dione derivatives
AU493335B2 (en) Piperidine derivatives
AU7732381A (en) "4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-pyridine derivatives"
PT68627A (en) Process for the preparation of 2-(2-furoyl)-1,4-dimethyl-pyridinium iodide